Anixa Biosciences, Inc. (ANIX)

Anixa Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Fiscal Year	Current	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022
Period Ending	Mar 13, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Market Cap	95	136	113	98	173	143
Market Cap Growth	-3.96%	20.99%	14.50%	-43.15%	20.77%	186.96%
Enterprise Value	80.87	120.13	91.86	73.73	142.76	107.16
Last Close Price	2.83	4.13	3.50	3.16	5.60	4.77
PE Ratio	-	-	-8.97	-9.87	-12.44	-10.60
PS Ratio	-	-	-	468.66	-	279.97
PB Ratio	6.28	8.99	5.64	4.04	5.96	4.04
P/TBV Ratio	-	-	5.58	4.02	5.86	3.85
P/FCF Ratio	-	-19.01	-15.36	-15.85	-26.67	-29.03
P/OCF Ratio	-	-19.01	-15.36	-15.85	-26.67	-29.03
EV/Sales Ratio	-	-	-	351.10	-	209.31
EV/EBITDA Ratio	-	-10.30	-6.66	-6.72	-10.32	-8.20
EV/EBIT Ratio	-	-10.27	-6.64	-6.70	-10.29	-8.16
EV/FCF Ratio	-	-16.75	-12.52	-11.88	-21.99	-21.70
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02
Debt / FCF Ratio	-0.03	-0.03	-0.03	-0.03	-0.03	-0.05
Net Debt / Equity Ratio	-0.93	-0.99	-0.98	-0.97	-1.01	-1.00
Net Debt / EBITDA Ratio	1.27	1.28	1.43	2.16	2.13	2.71
Net Debt / FCF Ratio	1.87	2.09	2.69	3.81	4.54	7.18
Asset Turnover	-	0	0	0.01	0	0.02
Quick Ratio	11.49	7.71	8.04	11.89	14.60	28.13
Current Ratio	12.18	8.08	8.54	12.50	14.83	28.35
Return on Equity (ROE)	-74.83%	-67.17%	-60.10%	-38.51%	-43.74%	-61.02%
Return on Assets (ROA)	-70.46%	-62.12%	-58.71%	-39.37%	-41.62%	-57.48%
Return on Invested Capital (ROIC)	1864.92%	1283.00%	2510.16%	1408.06%	1410.78%	1826.36%
Return on Capital Employed (ROCE)	-78.48%	-70.48%	-64.96%	-42.46%	-43.80%	-60.74%
Earnings Yield	-10.86%	0.00%	-11.14%	-10.13%	-8.04%	-9.43%
FCF Yield	-7.25%	-5.26%	-6.51%	-6.31%	-3.75%	-3.44%
Buyback Yield / Dilution	-1.67%	-1.67%	-3.03%	-0.37%	-0.26%	-22.02%

Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q